- Home
- OPTN vs COYA Comparison
OPTN vs COYA Comparison
Compare OPTN & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- COYA
- Stock Information
- Founded
- OPTN 2010
- COYA 2020
- Country
- OPTN United States
- COYA United States
- Employees
- OPTN N/A
- COYA N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- OPTN Health Care
- COYA Health Care
- Exchange
- OPTN Nasdaq
- COYA Nasdaq
- Market Cap
- OPTN 78.4M
- COYA 93.9M
- IPO Year
- OPTN 2017
- COYA 2022
- Fundamental
- Price
- OPTN $6.38
- COYA $5.38
- Analyst Decision
- OPTN Strong Buy
- COYA Strong Buy
- Analyst Count
- OPTN 3
- COYA 4
- Target Price
- OPTN $16.67
- COYA $16.25
- AVG Volume (30 Days)
- OPTN 60.7K
- COYA 62.0K
- Earning Date
- OPTN 03-06-2025
- COYA 11-06-2024
- Dividend Yield
- OPTN N/A
- COYA N/A
- EPS Growth
- OPTN N/A
- COYA N/A
- EPS
- OPTN N/A
- COYA N/A
- Revenue
- OPTN $75,672,000.00
- COYA $9,554,315.00
- Revenue This Year
- OPTN $13.42
- COYA N/A
- Revenue Next Year
- OPTN $38.54
- COYA $87.80
- P/E Ratio
- OPTN N/A
- COYA N/A
- Revenue Growth
- OPTN 5.13
- COYA N/A
- 52 Week Low
- OPTN $4.82
- COYA $4.75
- 52 Week High
- OPTN $31.50
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- OPTN 49.78
- COYA 38.98
- Support Level
- OPTN $5.16
- COYA $5.52
- Resistance Level
- OPTN $6.97
- COYA $6.14
- Average True Range (ATR)
- OPTN 0.66
- COYA 0.44
- MACD
- OPTN 0.10
- COYA -0.01
- Stochastic Oscillator
- OPTN 71.08
- COYA 5.13
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.